L 659989
Code | Size | Price |
---|
TAR-T24314-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24314-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24314-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
L 659989 is an antagonist of the Platelet-activating factor receptor.
CAS:
129314-27-8
Formula:
C24H32O8S
Molecular Weight:
480.57
Purity:
0.98
SMILES:
CCCOc1c(OC)cc(cc1S(C)(=O)=O)C1CCC(O1)c1cc(OC)c(OC)c(OC)c1
References
1. Birk-S?rensen L, Kerrigan CL, Wang C. Platelet activating factor antagonism in pure skin flaps exposed to ischaemia-reperfusion injury. Scand J Plast Reconstr Surg Hand Surg. 1999 Jun;33(2):155-61. PubMed PMID: 10450571.
2. G?mez-Mu?oz A, O'Brien L, Steinbrecher UP. The platelet-activating factor receptor antagonist L-659,989 inhibits phospholipase D activity. Biochim Biophys Acta. 1999 May 18;1438(2):247-52. PubMed PMID: 10320807.
3. Stotland MA, Kerrigan CL. The role of platelet-activating factor in musculocutaneous flap reperfusion injury. Plast Reconstr Surg. 1997 Jun;99(7):1989-99; discussion 2000-1. PubMed PMID: 9180723.
4. Herbertson MJ, Werner HA, Walley KR. Platelet-activating factor antagonism improves ventricular contractility in endotoxemia. Crit Care Med. 1997 Feb;25(2):221-6. PubMed PMID: 9034254.